BackEcho Therapeutics Overview
Echo Therapeutics, Inc.

Echo Therapeutics Price to Book Ratio

Valuation check: ECTE's P/B ratio is 0.0, below the sector sector average of 4.9.

Get informed when a big investor buys or sells

+ Follow

Price to Book

-0.00

Price to Book Ratio

-0.00

The Price-to-Book ratio compares a company's market value to its book value. A lower P/B ratio may suggest that the stock is undervalued relative to its assets.

Price to Book (Comparison Companies)

Loading

Price to Book Ratio History

Loading

Price to Book Ratio Comparison

Loading

Echo Therapeutics (ECTE) FAQ

The latest P/B ratio for ECTE is 0.0. That is below the sector sector average of 4.9. Investors often review this figure alongside Echo Therapeutics's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ECTE currently prints 0.0 for P/B ratio, while the sector average sits near 4.9. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Echo Therapeutics's growth, margins, and balance sheet.

A P/B ratio of 0.0 for Echo Therapeutics is not 'good' or 'bad' on its own. Compare it with the peer average (4.9) and with ECTE's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ECTE's P/B ratio (0.0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.